Claire Catherinet

Analyst, Crossover Fund


Claire joined Sofinnova Partners in February 2021 within the Crossover team. Prior to joining Sofinnova Partners, Claire served as an analyst at Andera Partners within the Life Sciences team where she identified and invested in biotech and medtech companies. She obtained her PhD in Hemato-Oncology from Paris Diderot University conducted at Institut Curie where she worked on elucidating signaling pathways involved in the activity of leukemic-initiating cells in T cell acute lymphoblastic leukemia (T-ALL). She also holds a MSc degree from the French engineering school Agrocampus Ouest and a degree in Biopharmaceutical Management from ESCP Business School. Her research has been published in journals such as Nature Communications and Cancer Cell.